Browse by UCL Departments and Centres
![]() | Up a level |
Group by: Author | Type
Number of items: 19.
C
| Craig, CEH and Quaglia, A and Savage, K and Lowdell, MW and Selden, C and Sim, R and North, J and Prentice, HG and Hodgson, H and Dhillon, AP (2003) Hepatocyte progenitor cells in massive hepatic necrosis. In: JOURNAL OF PATHOLOGY. (pp. 2A - 2A). JOHN WILEY & SONS LTD |
| Craig, CEH and Quaglia, A and Savage, K and Lowdell, MW and Seldon, C and Sim, R and North, J and Prentice, HG and Hodgson, H and Dhillon, AP (2003) Hepatocyte progenitor cells in massive hepatic necrosis. JOURNAL OF HEPATOLOGY , 38 38 - 38. |
D
| Davies, JK and Joh, MB and Prentice, HG and Lowdell, MW (2003) Potentiating the MLR prior to selective depletion of alloreactive cells: investigating the use of pre-treatment of stimulatory T cells with OKT3. In: Biology of Blood and Marrow Transplantation. |
| Davies, JK and Koh, MB and Verfuerth, S and Mackinnon, S and Lowdell, MW (2003) Selective depletion of CD69+ alloreactive donor T-cells by immunomagnetic sorting retains anti-viral activity, T-cell receptor V beta repertoire and functional T-regulatory cells within the donor cell pool. In: BLOOD. (pp. 965A - 965A). AMER SOC HEMATOLOGY |
| Davies, JK and Koh, MBC and Verfeurth, S and MACKINNON, S and Lowdell, MW (2003) Selective depletion of CD69+ alloreactive donor T-cells by immunomagnetic sorting retains anti-viral activity, T-cell receptor V beta repertoire and functional T-regulatory cells. In: (pp. 965 - ?). |
| Davies, JK and Lowdell, MW (2003) New advances in acute graft-versus-host disease prophylaxis. TRANSFUSION MED , 13 (6) 387 - 397. |
| Davies, JK and Marden, C and Sviland, L and Lowdell, MW (2003) Alloreactive NK cells do not mediate GvHD in the human skin explant model - Implications for development of an allogeneic NK cell recipient conditioning approach. BLOOD , 102 (11) 3542 - ?. |
| Davies, JK and Marden, C and Sviland, L and Lowdell, MW (2003) Alloreactive NK cells do not mediate GvHD in the human skin explant model - Implications for development of an allogeneic NK cell recipient conditioning approach. In: BLOOD. (pp. 951A - 951A). AMER SOC HEMATOLOGY |
| Davies, JK and Marden, CM and Sviland, L and Lowdell, MW (2003) Alloreactive NK cells do not mediate GvHD in the human skin explant model - implications for development of an allogenic NK cell recipient conditioning approach. In: (pp. 951 - ?). |
F
| Folarin, NI and Baker, RJ and Lowdell, MW and Wickremasinghe, RG and Marks, AJ and Hoffbrand, AV and Mehra, AB and Ganeshaguru, K (2003) ZAP-70 detecting by flow cytometry in cells from chronic lymphocytic leukaemia patients using a highly fluorescent Alexa Flour dye. In: BLOOD. (pp. 347B - 348B). AMER SOC HEMATOLOGY |
G
| Ganeshaguru, K and Jones, DT and Folarin, NI and Marks, AJ and Addison, E and North, JM and Lowdell, MW and Hoffbrand, AV and Mehta, AB and Wickremasinghe, RG (2003) Ansamysins synergise with conventional drugs in apoptotic killing of B-chronic lymphocytic leukemia (CLL) cells. In: BLOOD. (pp. 349B - 349B). AMER SOC HEMATOLOGY |
L
| Lowdell, MW (2003) "Out damned spot": ex vivo purging revisited. BLOOD , 102 (12) 3860 - 3861. |
| Lowdell, MW (2003) Natural killer cells in haematopoietic stem cell transplantation. TRANSFUSION MED , 13 (6) 399 - 404. |
M
| Marden, CM and North, J and Little, A and Madrigal, JA and Lowdell, MW (2003) In vitro expansion of non-alloreactive leukaemia-restricted T-cells in an HLA-mismatched setting. In: (pp. 964 - ?). |
| Marden, CM and North, J and Little, AM and Madrigal, JA and Lowdell, MW (2003) In vitro expansion of non-alloreactive leukaemia-restricted T-cells in an HLA-mismatched setting. BLOOD , 102 (11) 3591 - ?. |
| Marden, CM and North, J and Little, AM and Madrigal, JA and Lowdell, MW (2003) In vitro expansion of non-alloreactive leukaemia-restricted T-cells in an HLA-mismatched setting. In: BLOOD. (pp. 964A - 964A). AMER SOC HEMATOLOGY |
O
| Orleans-Lindsay, JK and Deru, A and Craig, JIO and Prentice, HG and Lowdell, MW (2003) In vitro co-stimulation with anti-CD28 synergizes with IL-12 in the generation of T cell immune responses to leukaemic cells; a strategy for ex-vivo generation of CTL for immunotherapy. CLIN EXP IMMUNOL , 133 (3) 467 - 475. |
P
| Pamphilon, DH and Lowdell, MW (2003) Stem cells and immunotherapy. TRANSFUSION MED , 13 (6) 323 - 324. |
S
| Smith, L and Lowdell, MW (2003) Quality issues in stem cell and immunotherapy laboratories. TRANSFUSION MED , 13 (6) 417 - 423. |


